Asthma causes approximately 1,000 deaths each year in France despite being a common chronic disease [2, 3].

This persistent mortality rate highlights a gap in public health awareness and the systemic underestimation of a condition that affects millions of citizens. The disparity between the high prevalence of the disease and the lack of public urgency suggests that many patients may not be receiving adequate long-term care.

Data indicates that over 4 million individuals in France live with asthma [1]. This population includes a significant number of children, with estimates showing that 14% to 16% of French children are affected by the condition [4].

Beyond fatalities, the burden on the healthcare system is substantial. There are approximately 60,000 asthma-related hospitalizations every year [2]. These figures illustrate the severe nature of the disease when it is not managed effectively through preventative medicine.

Experts said the disease remains underestimated because public awareness is low [2]. The burden of the illness is often hidden from the general public, even though the prevalence and mortality rates remain high.

While the condition is chronic and manageable, the frequency of emergency admissions suggests that a portion of the population lacks the necessary tools or knowledge to prevent crises. The high percentage of affected children further complicates the public health challenge, as early intervention is critical for lifelong respiratory health.

“Asthma causes approximately 1,000 deaths each year in France”

The persistence of 1,000 annual deaths and 60,000 hospitalizations indicates that asthma is often treated as a series of acute episodes rather than a chronic condition requiring consistent management. The high rate of pediatric cases suggests that environmental factors or diagnostic delays in childhood may be contributing to a long-term public health burden in France.